Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Sjoerd Zwart a Julius Center for General Practice
and Patient-oriented Research, University Medical Center Utrecht, 3584 CG Utrecht, Netherlands, b Laboratory for Microbiology and Infectious Diseases,
Isala Clinics, Zwolle, Netherlands, c Organisation for
Advice on Research and Policymaking, Grave, Netherlands
Correspondence to: S Zwart s.zwart{at}med.uu.nl
Objective:
To assess whether treatment with penicillin for three days and the traditional treatment for seven days were equally as effective at accelerating resolution of symptoms in patients
with sore throat compared with placebo.
Design:
Randomised double blind placebo controlled trial.
Setting:
43 family practices in the Netherlands.
Participants:
561 patients, aged 15-60 years, with
sore throat for less than seven days and at least three of the four Centor criteria
that is, history of fever, absence of cough, swollen tender anterior cervical lymph nodes, and tonsillar exudate. 142 patients were excluded for medical reasons and 73 needed penicillin.
Interventions:
Patients were randomly assigned to
penicillin V for seven days, penicillin V for three days followed by
placebo for four days, or placebo for seven days.
Main outcome measures:
Resolution of symptoms in the
first week, eradication of bacteria after two weeks, and recurrences of
sore throat after two, four, and six months.
Results:
Symptoms resolved 1.9 and 1.7 days earlier in
patients taking penicillin for seven days than in those taking penicillin for three days or placebo respectively. Symptoms resolved 2.5 days earlier in patients with group A streptococci and 1.3 days
earlier in patients with high colony counts of non-group A
streptococci. 23 (13%) of the placebo group had to be given antibiotics later in the week because of clinical deterioration; three
developed a peritonsillar abscess. The eradication rate for group A
streptococci was 72% in the seven day penicillin group, 41% in the
three day penicillin group, and 7% in the placebo group. Sore throat
recurred more often in the three day penicillin group than in the seven
day penicillin or placebo groups.
Conclusion:
Penicillin treatment for seven days was
superior to treatment for three days or placebo in resolving symptoms
of sore throat in patients with group A streptococcal pharyngitis and,
possibly, in those with non-group A streptococcal pharyngitis.
Read all Rapid Responses